Venous Ulcer Treatment - 8-Weeks Post Percutaneous TIRS Technique - Page 20 (Image uploaded)
-
Upload
veinexpertsorg -
Category
Documents
-
view
217 -
download
0
description
Transcript of Venous Ulcer Treatment - 8-Weeks Post Percutaneous TIRS Technique - Page 20 (Image uploaded)
Etiology and Treatment of Venous Ulcers
11/26/12
Ronald Bush, MD, FACS
Peggy Bush, APN
1
Treating venous leg ulcers is time-consuming and affects patients’ quality
of life. Venous ulcers affect approximately 2 percent of the adult population.
Millions of dollars are spent each year on the care of venous ulcers. At this time,
there is no consensus on the best therapy. Compression therapy has been the
main treatment strategy.
In this discussion, the etiology from a hemodynamic and cellular aspect
will be examined. Adjunctive treatments both medically and surgically will be
outlined. Finally, a new treatment option will be introduced known as ‘Terminal
Interruption of the Reflux Source,’ (TIRS). This technique was published in
Perspectives in Vascular Surgery and Endovascular Therapy, 2010.
The common factor for venous ulcers is increased ambulatory venous
pressure. A pressure above 45 mmHg increases the risk of ulceration. The
higher the pressure, the greater is the risk of eventual tissue necrosis.(1) The
increased pressure may be due solely to reflux at some point in the venous
system or co-exist with other factors. (2)
When evaluating a patient with a venous ulcer, an understanding of
venous pathophysiology and the complex interaction at the cellular level must be
understood. The etiology of the increase venous pressure should be
documented. This may be from a superficial, deep, perforating vessel or a
combination of any of the three. Other contributing factors such as abdominal
outflow compression or problems with venous or arterial capacity may be
present.
2
The eventual goal if possible is to provide relief of the increased venous
pressure. This will ensure the best possible outcome and help reduce further
ulcerations. Most therapy is directed at the local level when the patient is first
seen in the clinic and this is usually in the form of compression therapy.
Compression therapy with either elastic or inelastic dressings has been
the historical treatment. (3) (4) As compliance increases, so do the healing rates.
Even with compression alone, there is still a high recurrence rate. (4) (5)
Other adjuncts to improving ulcer healing have been described. Medical therapy
has included aspirin, rutosides, and pentoxyphine. (6) (7) (8) As always, local wound
care is essential and irrigation and debridement of devitalized tissue is essential.
At the ‘Midwest Vein and Laser Center’, Dayton, Ohio, debridement is
often carried out using 3 ‐10cc syringes with saline connected to a 30‐gauge
needle. This technique in effect directs a high-pressure stream of saline that is
directed at the ulcer base. Debridement is very effective and easily tolerated by
the patient.
Countless dressings have been advocated for ulcers and these range
from gauze to impregnated foam dressings. Silver impregnated dressings are
used in our clinic when there is evidence of infection locally. However, there is no
evidence in the literature of the superiority of one dressing over the other in
promoting wound healing.
Skin grafts have been used as an adjunct in wound healing for venous
ulcers. Grafts include full thickness punch grafts, xenografts, or allografts. To
date, in an updated review on skin grafting for venous ulcers; bi-layer artificial
3
skin, used in association with compression dressings, increased ulcer healing
compared to compression alone. (10) (11) In the study by (Falanga et, al, 1998),
healing at 6 months was only 63% with allogenic human skin equivalent
compared to a 43% with compression alone. (10)
Surgical techniques such as, stripping the greater saphenous vein (11), (12),
subfascial perforator ligation, (13) endoluminal thermal ablation, (15) and minimally
invasive perforator therapy, (16) have been used as adjuncts in the treatment of
venous ulcers. Non‐targeted foam sclerotherapy has also been mentioned as a
treatment modality. (16)(17) Except for foam sclerotherapy, none of these
procedures have proven to increase the healing rate of venous ulcers. The above
adjunctive procedures are mostly directed at preventing future occurrences.
Recently, a technique, ‘Terminal Interruption of the Reflux Source (TIRS)
has been introduced. (18) The TIRS technique targets only those vessels in close
proximity to the venous ulcer. The basis of this theory is that venous ulceration is
a local manifestation of a systemic problem. The high venous pressure in a vein
or veins draining the ulcer bed, or in some instances a perforator directly in
continuity with the ulcer, is responsible for the local phenomena of ulceration. If
the venous hypertension is relieved, then healing should accelerate.
When using the TIRS technique, patients at Midwest Vein and Laser
Center had rapid healing of ulcers when compared to compression alone, or
compression with other adjunctive procedures. In a series of twenty patients
treated with the TIRS technique, healing occurred in ninety percent of patients
4
within 8 weeks. All patients had been compliant with compression for 18-24
months prior to treatment. (Bush, 2010)
The exact mechanism of action at the microscopic level is as yet unknown
in the TIRS technique. The genesis of ulceration at the microscopic level is
generally believed to be an inflammatory response. According to this theory,
continuous high pressure leads to eventual necrosis. The necrosis is mediated
by complex interaction at the cellular level. Rapid healing observed after
occluding these high- pressured venous effluents with foam sclerotherapy must
be related to a marked reduction in ambulatory venous pressure at the local
level. Unfortunately, there is no reliable means to measure pressures in smaller
distal venous channels, or for that fact at the tissue level. Hence an assumption
is made that healing is mediated through a local reduction of venous pressure at
the ulcer site. The response has been rapid in most patients, however, there may
be other mechanisms that are also contributing which as yet are not known.
The TIRS technique requires good interpretive ultrasound skills, and the
ability to safely deliver the foamed sclerotherapy with the aid of ultrasound
guidance. Only the most distal venous branches draining the area of the ulcer
are identified. In some patients, especially those with anterior calf ulcers, a
perforator leading directly to the ulcer bed may be identified. The proximal source
of reflux, i.e. saphenous vein, classic posterior tibial perforator, or other source
proximally is ignored. Only the distal vessel or vessels are targeted, initially.
5
Vessels under the ulcer bed, somehow you must get the foam here, by direct puncture or by introducing it through a superior or inferior vessel close to the circumference of the ulcer. When these vessels clot, this equates to an internal compression, which is more effective than external compression. Copyright 2011 by www.bushvenouslectures.com
Using ultrasound guidance, these vessels are cannulated with needle
penetration through normal skin, as far from the ulcer margin as possible. A 3 cc
syringe and a 22‐gauge needle are used in our clinic. Cannulation is done
superior to the ulcer if chronic skin change exist inferiorly. After penetrating the
target vessel, the foam is slowly injected.
6
Using ultrasound to demonstrate vessels draining ulcer bed -‐ Copyright 2011 by www.bushvenouslectures.com
7
Local anesthesia to skin delivered with 30-‐gauge needle with tumescent solution -‐ Copyright 2011 by www.bushvenouslectures.com
8
Percutaneous puncture of target vessel -‐ Copyright 2011 by www.bushvenouslectures.com
9
Aspirating blood after puncture to confirm needle placement -‐ Copyright 2011 by www.bushvenouslectures.com
10
Injecting Sotradecol foam -‐ Copyright 2011 by www.bushvenouslectures.com
11
Injecting Sotradecol foam -‐ Copyright 2011 by www.bushvenouslectures.com
In our clinic, a 4:1 mixture of Sotradecol and C02 is used. After
injecting the foamed solution, compression is applied and local wound care is
done. The patient is rescanned at weekly intervals and foam injections are
repeated if necessary. A 1 percent concentration is used, unless extenuating
circumstances, such as concurrent anticoagulation or high flow exists. A 3
percent foamed solution of Sotradecol is then used.
Definitive treatment of the proximal reflux source such as thermal ablation
of the saphenous vein or perforator interruption is done at a later date, to help
prevent future ulcer occurrences. In some cases, concurrent treatment can be
done. However, many times insurance requirements must be addressed and the
more definitive procedures are done 6-‐8 weeks after the first ultra sound guided
12
treatment. Most patients have had rapid healing by this time and local infection
and pain have abated.
13
Venous Ulcers: The TIRS Technique Through a Percutaneous Approach
69- year old male with recurrent venous ulceration right lower leg; the
patient had a previous saphenous vein ablation three years ago with foam
injection of the ulcer bed 8 weeks before the procedure. The ulcer healed
completely before the ablation.
Now, presents with recurrent venous ulcer inferior to the old site. Popliteal
vein shows no reflux, posterior tibial vein shows no reflux, but there is an
incompetent perforator that drains the ulcer bed. This can be seen in figures 1-3.
The ulcer bed has been injected once before percutaneously with a 25-gauge
needle. This is a quick and relatively painless way to deliver foam into the
underlying ulcer bed.
In almost all patients, a small superficial venous tributary can be found in
close proximity to the ulcer. This has now become my preferred method of
performing the TIRS Technique. It is also much more comfortable for the patient.
This provides excellent access to the ulcer bed. Make sure there is good blood
return in your tubing before injecting the foam. Foam is much safer to inject and
much more effective than liquid. This can be seen in Figure 4. Figure 5 shows
the foam in the ulcer bed after the percutaneous injection with the 25-gauge
needle.
The patient should be seen in one week and any patent vessels under the
ulcer bed are obliterated with foam. Foam sclerotherapy provides an excellent
internal compression dressing. In Fact, this patient had a reduction of one half of
the original ulcer size in 2-weeks.
14
15
16
17
18
11/26/12
The above US shows the clotted vessels under the ulcer bed, post 2nd injection. The ulcer continues to heal rapidly. The perforator is still patent, but is no longer in continuity with the vessels that are draining the ulcer bed.
As long as these vessels remain thrombosed, rapid ulcer healing will occur. I may have to target the perforator by standard US guided techniques in the future. However, if the ulcer heals and there are no further problems, I will leave the perforator alone at this time.
As you can see from the US image, the clotted vessels form a barrier to the increased pressure in the deep system.
19
1/12/13
8-weeks post Percutaneous TIRS Technique
Venous Ulcer 8-Weeks Post Percutaneous TIRS Technique - Copyright 2013 by www.veinexperts.org
20
12/18/12 - Co-existing GSV reflux and posterior tibial perforator in a patient with venous ulcers
Many times I have encountered patients with C5- C6 disease that have both GSV reflux and also a pathologic perforator of the post tibial vein (Cockett’s). It is known that both of these conditions may cause ulcerations. When both co-exist two questions must be answered. What is the primary etiology and what abnormality should be addressed first.
The answer is illustrated in the following case. This case may be the best illustration of the pathogenesis of both GSV reflux and post tibial perforator occurring together.
Remember, a perforator that is abnormal is usually a secondary occurrence. However, once abnormal, it may become the primary origin of C5 – C6.
In the following presentation, you can see that GSV reflux occurred to the ankle level. Communicating veins then course under the indurated, inflamed ulcer to connect to a large post tibial perforator. There is also a smaller perforator at the ankle level.
The inderated-inflamed area is in continuity with the large posterior perforator. The post tibial vessels are normal in size until the origin of the perforator.
Above this level, they are also normal. This picture is one of secondary pathology due to superficial venous overload.
The GSV is treated first, and if syptoms persist which they usually do, then the perforator is addressed.
These US images and videos illustrate the most common cause of post tibial perforator pathology- GSV reflux.
21
22
Click on image to see video
Ultrasound of Posterior Tibial Perforator
23
24
25
The vessels are marked by the red arrow communicate to both the GSV and the vessels under the ulcer bed which then connect to the posterior tibial perforator
26
References
1. Payne S, London N, Newland C, et al. Ambulatory venous pressure:
Correlation with skin condition and role in identifying surgically correctible
disease. Eur J Vasc Endovasc Surg. 1996;11:195-‐200.
2. Raju S, Neglen P, Carr-‐White P, et al. Ambulatory venous hypertension:
Component analysis in 373 limbs. Vasc Endovascular Surg. 1999;33:257-‐
266.
3. Fletcher A, Cullum N, Sheldon T. A systematic review of compression
treatment for venous leg ulcers. BMJ. 1997;315:576-‐580.
4. Erickson C, Lanza D, Karp D, et al. Healing of venous ulcers in an
ambulatory
care program: the roles of chronic venous insufficiency and patient
compliance. J Vasc Surg. 1995;22(5):629-‐636.
5. Scriven J, Taylor L, Wood A, et al. A prospective randomized trial of four-‐
layer
versus short stretch compression bandages for the treatment of venous
leg
ulcers. Ann R Coll Surg Engl. 1998;80:215-‐220.
6. Falanga V, Fujitani R, Diaz C, et al. Systemic treatment of venous leg
ulcers
with high doses of pentoxifylline: Efficacy in a randomized, placebo-‐
controlled trial. Wound Repair Regen. 1999;7:208-‐13.
7. Colgan M, Dormandy J, Jones, P, et al. Oxpentifylline treatment of venous
27
ulcers of the leg. BMJ. 1990;300:972-‐975.
8. Gohel M, Davies A. Pharmacological agents in the treatment of venous
disease: An update of the available evidence. Current Vascular
Pharmacology. 7(3):303-‐8, 2009 Jul.
9. Jones J, Nelson E. Skin grafting for venous leg ulcers. Cochrane
Database Syst Rev.. 2007;18;(2).
10.Falanga V, Margolis D, Alvarez O, et al. Rapid healing of venous ulcers
and lack of clinical rejection with an allogeneic cultured human skin
equivalent. Arch Dermatol. 1998;134(3):293-‐300.
11.Barwell J, Davies C, Deacon J, et al. Comparison of surgery and
compression with compression alone in chronic venous ulceration
(ESCHAR STUDY): Randomized controlled trial. Lancet.
2008;363(9424):1854-‐1859.
12.Homans J. The operative treatment of varicose veins and ulcers, based on
classification of these lesions. Surg Gynecol Obstet. 1916; 22:143-‐158.
13.Pierik E, Van Urk H, Hop W, Wittens C. Endoscopic versus open
subfascial division of incompetent perforating veins in the treatment of
venous leg ulceration: A randomized trial. J Vasc Surg. 1997;26(6):1049-‐
1054)
14.Glovicski P, Bergan J, Rhodes J, Canton L, Harmsen S, Ilstrup D. Mid-‐
term results of endoscopic perforator vein interruption for chronic venous
insufficiency: Lessons learned from the North American subfascial
28
endoscopic perforator surgery registry. The North American Study Group.
J Vasc Surg. 1999;29(3):489-‐502.
15.Rautio T, Ohinmaa A, Perala J, et al. Endovenous obliteration versus
conventional stripping operation in the treatment of primary varicose veins:
A randomized controlled trial with comparison of the costs. J Vasc Surg.
2002;35(5):958-‐965.
16.Poblete H, Elias S. Venous Ulcers: New options in treatment: Minimally
invasive vein surgery. Journal of the Am Coll of Certified Wound
Specialists. 2009;1(1):12-‐19.
17.Hertzman, P, Owens R. Rapid healing of chronic venous ulcers following
ultrasound-‐guided foam sclerotherapy. Phlebology. 2007; 22:34-‐39.
18.Bush R. Terminal interruption of the reflux source for the treatment of
venous ulcers. Presented at the American College of Phlebology. 2009.
19.Bush, R. New technique to heal venous ulcers: Terminal interruption of the
reflux source (TIRS). Perspectives in Vascular Surgery and Endovascular
Therapy. 2010;22(3).
29